Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy

Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, causes adult T-cell leukemia-lymphoma, HTLV-1 associated myelopathy/tropical spastic paraparesis, and HTLV-1 uveitis. Currently, no antiretroviral therapies or vaccines are available for HTLV-1 infection. This study aimed to develop an antib...

Full description

Bibliographic Details
Main Authors:	Yasuyoshi Hatayama, Yutaro Yamaoka, Takeshi Morita, Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Mayuko Nishi, Yayoi Kimura, Makoto Mitsunaga, Tadayuki Iwase, Hirokazu Kimura, Naoki Yamamoto, Akifumi Takaori-Kondo, Hideki Hasegawa, Akihide Ryo
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Viruses
Subjects:	HTLV-1 monoclonal antibody near infrared photoimmuno-antimicrobial strategy IR700
Online Access:	https://www.mdpi.com/1999-4915/14/10/2153

Similar Items

Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma
by: Mayuko Nishi, et al.
Published: (2023-11-01)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
by: Yusuke Nakai, et al.
Published: (2022-11-01)

MAL Inhibits the Production of HIV-1 Particles by Sequestering Gag to Intracellular Endosomal Compartments
by: Kei Miyakawa, et al.
Published: (2022-03-01)

Tuberculous meningoencephalomyelitis and coinfection with HTLV-I + HTLV-II: case report Meningoencefalomielite tuberculosa e coinfecção por HTLV-I + HTLV-II: relato de caso
by: Marcio Menna-Barreto, et al.
Published: (2006-03-01)

Epidemiological Aspects and World Distribution of HTLV-1 Infection
by: Antoine eGessain, et al.
Published: (2012-11-01)

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases
by: Norbert Kassay, et al.
Published: (2021-02-01)

Prevalence of anti-HTLV-I & anti-HTLV-II antibodies in Blood donors in Bushehr Province
by: Mahmood Reza Poukarim, et al.
Published: (2004-02-01)

Editorial to the Research Topic Comparative studies between HTLV-1 and HTLV-2 function and pathobiology
by: Umberto eBertazzoni
Published: (2015-01-01)

Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis
by: Benoit eBarbeau, et al.
Published: (2013-08-01)

Carga proviral do HTLV-1 e HTLV-2: um método simples através da PCR quantitativa em tempo real HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR
by: Bruna Pedroso Tamegão-Lopes, et al.
Published: (2006-12-01)

Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects
by: Benjamin Usadi, et al.
Published: (2016-08-01)

Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2
by: Edward Lin, et al.
Published: (2022-12-01)

Tuning Rex rules HTLV-1 pathogenesis
by: Kazumi Nakano, et al.
Published: (2022-09-01)

Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis
by: P.A. Montanheiro, et al.
Published: (2005-11-01)

HTLV: It Is Time to Reach a Consensus on Its Nomenclature
by: Antonio Carlos Rosário Vallinoto, et al.
Published: (2022-04-01)

High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1
by: J. Primo, et al.
Published: (2009-08-01)

Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancreatic cancer
by: De Silva Pushpamali, et al.
Published: (2021-08-01)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
by: Takeshi Morita, et al.
Published: (2021-08-01)

HTLV-1 and HTLV-2 infections in patients with endemic mycoses in São Paulo, Brazil: A cross-sectional, observational study
by: Adele Caterino-de-Araujo, et al.
Published: (2022-11-01)

Post-transcriptional Regulation of HTLV Gene Expression: Rex to the Rescue
by: Donna M. D’Agostino, et al.
Published: (2019-08-01)

The need to accessorize: Molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle
by: Rajaneesh eAnupam, et al.
Published: (2013-09-01)

Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections
by: Gabriela de Melo Franco, et al.
Published: (2022-05-01)

HTLV no Brasil: informe Científico sobre o II Simpósio internacional
by: Maria do Socorro Pombo de Oliveira, et al.
Published: (2023-06-01)

Pathways of cell-cell transmission of HTLV-1
by: Claudine ePique, et al.
Published: (2012-10-01)

Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology Os Vírus T-Linfotrópicos Humanos tipo I (HTLV-I) e tipo II (HTLV-II) na Guiana Francesa: epidemiologia clínica e molecular
by: Mirdad Kazanji, et al.
Published: (2003-10-01)

Prevalence and genetic characterisation of HTLV-1 and 2 dual infections in patients with pulmonary tuberculosis in Central-West Brazil
by: Aline Garcia Kozlowski, et al.
Published: (2014-02-01)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
by: Akihito Koseki, et al.
Published: (2023-06-01)

Epidemiologia, fisiopatogenia e diagnóstico laboratorial da infecção pelo HTLV-I Epidemiology, physiopathogenesis and laboratorial diagnosis of the HTLV-I infection
by: Fred Luciano Neves Santos, et al.
Published: (2005-04-01)

Infecção pelo HTLV-I/II no Estado da Bahia HLTV-I/II infection in Bahia State, Brazil
by: Ana Pavlova C.R. Britto, et al.
Published: (1998-02-01)

Serological Evidence of HTLV-I and HTLV-II Coinfections in HIV-1 Positive Patients in Belém, State of Pará, Brazil
by: Vallinoto ACR, et al.
Published: (1998-01-01)

Magnetic resonance imaging in HTLV-I associated myelopathy Ressonância magnética na mielopatia associada ao HTLV-I
by: Aílton Melo, et al.
Published: (1993-09-01)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
by: Mohammad Mehdi Akbarin, et al.
Published: (2013-03-01)

HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma
by: Hiroo Katsuya, et al.
Published: (2023-08-01)

The Role of HBZ in HTLV-1-Induced Oncogenesis
by: Tiejun Zhao
Published: (2016-02-01)

HTLV: uma infecção estigmatizante?
by: Ionara Ferreira da Silva Garcia, et al.
Published: (2019-11-01)

Making Visible HTLV Infection in a Non-endemic Area of Argentina
by: Federico R. Simioli, et al.
Published: (2022-07-01)

Editorial: Prevention and control of human T lymphotropic viruses 1 and 2 (HTLV-1/2)
by: Luiz Fernando Almeida Machado, et al.
Published: (2022-08-01)

Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil
by: Leny Nascimento da Motta Passos, et al.
Published: (2014-07-01)

HTLV-3/STLV-3 and HTLV-4 Viruses: Discovery, Epidemiology, Serology and Molecular Aspects
by: Antoine Gessain, et al.
Published: (2011-07-01)

Biomarkers in a Cohort of HIV-Infected Patients Single- or Co-Infected with HTLV-1, HTLV-2, and/or HCV: A Cross-Sectional, Observational Study
by: Adele Caterino-de-Araujo, et al.
Published: (2022-09-01)